Abstract:【Objective】To study the expression levels of GRP78 and GRP94 and their clinicopathological significances in the adenocarcinoma,peritumoral tissues,adenomatous polyp and chronic cholecystitis of gallbladder.【Methods】 EnVisionTM immunohistochemistry for detecting expressive levels of GRP78 and GRP94 was used in the tissues of gallbladder adenocarcinoma(n =108),peritumoral tissues(n =46),adenomatous polyp(n =15) and chronic cholecystitis(n =35);The relevance of the two elements and clinicopathological features and survival time of patients of gallbladder adenocarcinoma was analyzed.【Results】 The positive frequencies of GRP78 and GRP94 were significantly higher in adenocarcinoma than that in peritumoral tissues,adenomatous polyp and chronic cholecystitis(P <0.01).The positive cases of GRP78 and/or GRP94 in the benign lesions showed moderate-or severedysplasia of gallbladder epithelia.The positive rates of GRP78 and GRP94 were significantly lower in well-differentiated adenocarcinoma,no-metastasis of lymph node and no-invasiveness of regional tissues than those in moderate-ly or poorly-differentiated adenocarcinoma,metastasis of lymph node and invasiveness of regional tissues(P <0.05 or P <0.01).Unitivariate Kaplan-Meier analysis showed that increased expression of GRP78(P =0.009) or GRP94(P =0.022) was associated with decreased overall survival.Multivariate Cox regression analysis showed that increased expression of GRP78(P =0.014) or GRP94(P =0.020) was an independent prognostic predictor in gallbladder adenocarcinoma.【Conclusions】 The expression levels of GRP78 and/or GRP94 might be important markers for reflecting the carcinogenesis,progression and biological behaviors and prognosis of gallbladder adenocarcinoma.The assays of GRP78 and/or GRP94 expressive levels might have important clinical values for guiding auxiliary therapy of gallbladder adenocarcinoma.Additional,the detection of GRP78 and/or GRP94 expressive levels in the benign lesions might have clinical significances on finding of gallbladder adenocarcinoma in the early stage.

Pathological significance of the expression of pituitary tumor transforming gene (PTTG) in gallbladder cancer tissues

VEGF, Flt-1 and KDR Mrna and Protein Expression in Primary Gallbladder Carcinoma and Their Correlation with Primary Gallbladder Carcinoma Clinicopathological Characteristics

Study on the expression of pituitary tumor-transforming(PTTG) and fragile histidine triad(FHIT) in gastric cancer and pericancerous tissues

The expression of pituitary tumor transforming gene (PTTG) in breast cancer and its clinical significance

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

Expression of PDGF-BmRNA in 108 Cases with Gallbladder Adenocarcinoma and Its Significance

Expression of Pituitary Tumor Transforming Gene in Human Gastric Carcinoma

Expression of PTEN Protein in Gastric Carcinoma, Adjacent Mucosa and Precancerous Lesions of Stomach and Its Significance

Expression of Protein Gene Product 9.5(PGP9.5) and Clinical Significances in the Benign and Malignant Lesions of Gallbladder

Expression of p53 upregulated modulator of apoptosis (PUMA) and C-myb in gallbladder adenocarcinoma and their pathological significance

Expressions of GRP78 and GRP94 in the benign and malignant lesions of gallbladder and their clinicopathological significance

Immunoreactivity and Prognostic Value of Tumor-Associated Glycoprotein 72 in Primary Gallbladder Carcinoma

Expression of insulin-like growth factor-binding protein-2 (IGFBP2) and matrix metalloproteinase-9 (MMP9) and its clinicopathologieal significances in benign and malignant lesions of gallbladder

Expression of hPTTG1 and bFGF in gallbladder carcinoma tissue and their correlation with angiogenesis

Elementary Studies on Effect of PTTG Gene Expression in Human Primary Hepatocellular Carcinogenesis and Its Mechanism

Expression of P504S and P63 and Their Clinicopathological Significances in the Benign and Malignant Lesions of Gallbladder.

Expressions and Clinical Significance of TGF-β1, MMP-2 in Gallbladder Carcinoma

Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma

Expression of Flt-4 in Primary Gallbladder Carcinoma and Analysis of Its Correlation with Clinical Pathological Characteristics

[Expression of Enhancer of Zesle Homolog 2 and Phosphatase and Tension Homolog and Its Clinicopathological Significance in Benign and Malignant Lesion of Gallbladder].

The Clinical Significance of MGMT, Hmlh1 and Hmsh2 Gene Expressions in Gallbladder Adenocarcinoma and Adjacent Tissues